Health
NIAID set to conduct large monoclonal SARS-CoV-2 antibody clinical trial – News-Medical.Net
A large clinical trial, known as the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-2), is set to take place, which aims to test monoclonal…
The coronavirus disease 2019 (COVID-19) pandemic continues to spread worldwide, with a new highly infectious strain identified in the UK, causing surges of new cases. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), COVID-19 can cause mild to severe illness, while some do not experience any symptoms at all.
A large clinical trial, known as the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-2), is set to take place, which aims to test monoclonal antibody…
-
General24 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Noosa News20 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News13 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General12 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final